Vascular pathobiology in chronic liver disease and cirrhosis - Current status and future directions

被引:221
|
作者
Iwakiri, Yasuko [1 ]
Shah, Vijay [2 ]
Rockey, Don C. [3 ]
机构
[1] Yale Univ Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[3] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
基金
美国国家卫生研究院;
关键词
Endothelial cell; Pericyte; Sinusoid; Pressure; Resistance; Therapy; NITRIC-OXIDE SYNTHASE; SINUSOIDAL ENDOTHELIAL-CELLS; PORTAL HYPERTENSIVE-RATS; HEPATIC STELLATE CELLS; SCANNING ELECTRON-MICROSCOPE; FIBROBLAST-GROWTH-FACTOR; FARNESOID X RECEPTOR; SMOOTH MUSCLE ACTIN; IN-VIVO; GENE-TRANSFER;
D O I
10.1016/j.jhep.2014.05.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic liver disease is associated with remarkable alterations in the intra- and extrahepatic vasculature. Because of these changes, the fields of liver vasculature and portal hypertension have recently become closely integrated within the broader vascular biology discipline. As developments in vascular biology have evolved, a deeper understanding of vascular processes has led to a better understanding of the mechanisms of the dynamic vascular changes associated with portal hypertension and chronic liver disease. In this context, hepatic vascular cells, such as sinusoidal endothelial cells and pericyte-like hepatic stellate cells, are closely associated with one another, where they have paracrine and autocrine effects on each other and themselves. These cells play important roles in the pathogenesis of liver fibrosis/cirrhosis and portal hypertension. Further, a variety of signaling pathways have recently come to light. These include growth factor pathways involving cytokines such as transforming growth factor beta, platelet derived growth factor, and others as well as a variety of vasoactive peptides and other molecules. An early and consistent feature of liver injury is the development of an increase in intra-hepatic resistance; this is associated with changes in hepatic vascular cells and their signaling pathway that cause portal hypertension. A critical concept is that this process aggregates signals to the extrahepatic circulation, causing derangement in this system's cells and signaling pathways, which ultimately leads to the collateral vessel formation and arterial vasodilation in the splanchnic and systemic circulation, which by virtue of the hydraulic derivation of Ohm's law (pressure = resistance x flow), worsens portal hypertension. This review provides a detailed review of the current status and future direction of the basic biology of portal hypertension with a focus on the physiology, pathophysiology, and signaling of cells within the liver, as well as those in the mesenteric vascular circulation. Translational implications of recent research and the future directions that it points to are also highlighted. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:912 / 924
页数:13
相关论文
共 50 条
  • [1] Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions
    Kreidieh, Malek
    Hamadi, Rachelle
    Alsheikh, Mira
    Al Moussawi, Hassan
    Deeb, Liliane
    GASTROENTEROLOGY RESEARCH, 2022, 15 (01) : 1 - 12
  • [2] Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
    Vajro, Pietro
    Lenta, Selvaggia
    Pignata, Claudio
    Salerno, Mariacarolina
    D'Aniello, Roberta
    De Micco, Ida
    Paolella, Giulia
    Parenti, Giancarlo
    ITALIAN JOURNAL OF PEDIATRICS, 2012, 38
  • [3] Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
    Pietro Vajro
    Selvaggia Lenta
    Claudio Pignata
    Mariacarolina Salerno
    Roberta D’Aniello
    Ida De Micco
    Giulia Paolella
    Giancarlo Parenti
    Italian Journal of Pediatrics, 38
  • [4] Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease
    Wruck, Wasco
    Graffmann, Nina
    Kawala, Marie-Ann
    Adjaye, James
    STEM CELLS, 2017, 35 (01) : 89 - 96
  • [5] Dietary nutrition for neurological disease therapy: Current status and future directions
    Mao, Xiao-Yuan
    Yin, Xi-Xi
    Guan, Qi-Wen
    Xia, Qin-Xuan
    Yang, Nan
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    Jin, Wei-Lin
    PHARMACOLOGY & THERAPEUTICS, 2021, 226
  • [6] Metformin Pharmacogenomics: Current Status and Future Directions
    Pawlyk, Aaron C.
    Giacomini, Kathleen M.
    McKeon, Catherine
    Shuldiner, Alan R.
    Florez, Jose C.
    DIABETES, 2014, 63 (08) : 2590 - 2599
  • [7] Treatment of Giardiasis: Current Status and Future Directions
    Watkins, Richard R.
    Eckmann, Lars
    CURRENT INFECTIOUS DISEASE REPORTS, 2014, 16 (02)
  • [8] Targeting von Willebrand disease: the current status and future directions of management therapies
    Franchini, Massimo
    Focosi, Daniele
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (11) : 871 - 878
  • [9] Multiple myeloma - current status and future directions
    Rasche, Leo
    Knop, Stefan
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (10): : 793 - 804
  • [10] Cancer stem cells: Current status and future directions
    Stoica, George
    VETERINARY JOURNAL, 2015, 205 (02) : 124 - 125